ArticleBMC public health2026
Emergence of pneumococcal meningitis outbreak in Northern Togo in 2023, lessons learned and challenges.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOutbreaks of Streptococcus pneumoniae (Spn) meningitis are uncommon, typically more severe with high mortality. In Epi-week 4, 2023, Oti-Sud district in Togo reached for the first time, the epidemic threshold with 13 Spn cases despite the introduction of PCV13 into the routine EPI in 2014. The outbreak was investigated to describe its magnitude and document lessons learned to inform preparedness and response for future outbreaks.
methodThis cross-sectional study analyzed Spn meningitis outbreak data from Oti-Sud district (Savanes region), Epi-week 49, 2022 to Epi-week 23, 2023 to describe the attack and case fatality rates (AR & CFR), patients’ sociodemographic and clinical characteristics across the district and its three surveillance zones (Z1, Z2 and Z3). Additionally, we analyzed routine surveillance data from Savanes region, Epi-week 1, 2016 to Epi-week 17, 2019 to compare Spn and Neisseria meningitis (Nm) case characteristics and scrutinized the Spn outbreak’s After Review Action report to document lessons learned. Meningitis’ case definitions and epidemic thresholds followed WHO guidelines. We performed descriptive analysis and summarized findings using median, ratio and proportions.
resultsEpidemic threshold was reached with a weekly AR of 10 cases per 100,000 population. A total of 153 cases was notified from Epi-week 49, 2022 to Epi-week 23, 2023 representing a cumulative AR of 117.4 and was 192.6 in Z1; Z2: 55.4 and Z3: 74.7. The cumulative CFR was 7.8%(12/153), ranged from 8.1%(6/74) in females and 7.6%(6/79) in males, p-value = 0.9132 with a significant difference within zones (Z1: 5.8%(6/104), Z2: 17.4%(4/23) and Z3: 7.7%(2/26), p-value < 0.0001). Female to male sex ratio was 0.48(74/153), median age: 15 years, IQR: [11–24] and all cases were from rural area. Spn outbreak showed parallels to Nm’s. Zone-based surveillance, continuous capacity building, systematic daily data analysis and monitoring, community engagement contributed to outbreak detection and community compliance to response measures. Key bottlenecks included limited laboratory testing capacity, absence of strain sequencing, incomplete routine vaccination records, and lack of sequelae data.
conclusionSpn meningitis outbreak emergence in northern Togo magnitude was high with similarities with Nm’s. Defeating meningitis by 2030 requires laboratory capacity reinforcement, comprehensive and accurate surveillance data including routine vaccination and sequalae data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.